News summary

Baltics get their first $71m cell therapy plant

Source: Longevity Technology • Published: 17 Sept 2026, 19:26

Summarized by Masters of Longevity from Longevity Technology.

A report previewing a news article about a new cell therapy and personalized medicine manufacturing center and its future research ambitions.

Baltics get their first $71m cell therapy plant
Key Takeaways
  • Northway Biotech opened a 3,500 m² cGMP facility in Vilnius to manufacture patient-specific cell therapies.
Read the full article at Longevity Technology ↗

Continue exploring

Recommended MoL Picks

MoL PickWhat Changes in the Human Hippocampus with Age?A study of 40 postmortem brains maps a midlife shift in immune cells and a wider loss of cellular and genome organisation—but it does not show how to prevent cognitive decline.MoL PickNucleotides and Longevity: Is the Evidence Ready?They help build DNA and keep cells working. Early human studies make nucleotide supplements interesting—but leave important questions about healthy ageing unanswered. Yet.MoL PickReducing Inflammation from Ageing Cells: What a Mouse Study FoundResearchers reduced the inflammatory signals released by cells that had stopped dividing. Older mice also improved on some strength and frailty tests. Whether this approach could help people remains unknown.